nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—NR0B1—Vincristine—kidney cancer	0.416	1	CbGbCtD
Vorinostat—HDAC4—nephron tubule—kidney cancer	0.00525	0.0477	CbGeAlD
Vorinostat—HDAC6—cortex of kidney—kidney cancer	0.00521	0.0474	CbGeAlD
Vorinostat—HDAC8—renal system—kidney cancer	0.00491	0.0446	CbGeAlD
Vorinostat—HDAC8—kidney—kidney cancer	0.00474	0.0432	CbGeAlD
Vorinostat—NCOR1—nephron tubule—kidney cancer	0.00457	0.0415	CbGeAlD
Vorinostat—HDAC4—cortex of kidney—kidney cancer	0.00449	0.0408	CbGeAlD
Vorinostat—HDAC11—renal system—kidney cancer	0.00428	0.0389	CbGeAlD
Vorinostat—HDAC4—gonad—kidney cancer	0.00428	0.0389	CbGeAlD
Vorinostat—NCOR1—renal system—kidney cancer	0.00415	0.0378	CbGeAlD
Vorinostat—HDAC11—kidney—kidney cancer	0.00414	0.0376	CbGeAlD
Vorinostat—NCOR1—kidney—kidney cancer	0.00401	0.0365	CbGeAlD
Vorinostat—HDAC3—nephron tubule—kidney cancer	0.004	0.0364	CbGeAlD
Vorinostat—NCOR1—cortex of kidney—kidney cancer	0.00391	0.0356	CbGeAlD
Vorinostat—HDAC11—gonad—kidney cancer	0.00384	0.0349	CbGeAlD
Vorinostat—NCOR1—gonad—kidney cancer	0.00372	0.0339	CbGeAlD
Vorinostat—HDAC1—nephron tubule—kidney cancer	0.00367	0.0334	CbGeAlD
Vorinostat—HDAC9—nephron tubule—kidney cancer	0.00361	0.0328	CbGeAlD
Vorinostat—NR0B1—gonad—kidney cancer	0.0035	0.0318	CbGeAlD
Vorinostat—HDAC3—cortex of kidney—kidney cancer	0.00343	0.0312	CbGeAlD
Vorinostat—HDAC1—renal system—kidney cancer	0.00333	0.0303	CbGeAlD
Vorinostat—HDAC3—cardiac atrium—kidney cancer	0.00326	0.0296	CbGeAlD
Vorinostat—HDAC1—kidney—kidney cancer	0.00322	0.0293	CbGeAlD
Vorinostat—HDAC1—cortex of kidney—kidney cancer	0.00314	0.0285	CbGeAlD
Vorinostat—HDAC9—cortex of kidney—kidney cancer	0.00309	0.0281	CbGeAlD
Vorinostat—HDAC1—gonad—kidney cancer	0.00299	0.0272	CbGeAlD
Vorinostat—HDAC1—cardiac atrium—kidney cancer	0.00299	0.0272	CbGeAlD
Vorinostat—HDAC2—nephron tubule—kidney cancer	0.00184	0.0168	CbGeAlD
Vorinostat—HDAC2—renal system—kidney cancer	0.00168	0.0152	CbGeAlD
Vorinostat—HDAC2—kidney—kidney cancer	0.00162	0.0147	CbGeAlD
Vorinostat—HDAC2—cortex of kidney—kidney cancer	0.00158	0.0144	CbGeAlD
Vorinostat—HDAC2—gonad—kidney cancer	0.0015	0.0137	CbGeAlD
Vorinostat—HDAC2—Temsirolimus—Everolimus—kidney cancer	0.00103	0.2	CbGdCrCtD
Vorinostat—HDAC2—Sirolimus—Temsirolimus—kidney cancer	0.00103	0.2	CbGdCrCtD
Vorinostat—HDAC2—Everolimus—Temsirolimus—kidney cancer	0.00103	0.2	CbGdCrCtD
Vorinostat—HDAC2—Sirolimus—Everolimus—kidney cancer	0.00103	0.2	CbGdCrCtD
Vorinostat—HDAC2—Gefitinib—Erlotinib—kidney cancer	0.00103	0.199	CbGdCrCtD
Vorinostat—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000297	0.00124	CcSEcCtD
Vorinostat—Angioedema—Sunitinib—kidney cancer	0.000297	0.00124	CcSEcCtD
Vorinostat—Loss of consciousness—Sorafenib—kidney cancer	0.000297	0.00123	CcSEcCtD
Vorinostat—Oedema peripheral—Gemcitabine—kidney cancer	0.000295	0.00123	CcSEcCtD
Vorinostat—Cough—Sorafenib—kidney cancer	0.000295	0.00123	CcSEcCtD
Vorinostat—Neutropenia—Paclitaxel—kidney cancer	0.000293	0.00122	CcSEcCtD
Vorinostat—Diarrhoea—Temsirolimus—kidney cancer	0.000292	0.00122	CcSEcCtD
Vorinostat—Anorexia—Erlotinib—kidney cancer	0.000292	0.00122	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000291	0.00121	CcSEcCtD
Vorinostat—Leukopenia—Sunitinib—kidney cancer	0.000291	0.00121	CcSEcCtD
Vorinostat—Asthenia—Pazopanib—kidney cancer	0.000288	0.0012	CcSEcCtD
Vorinostat—Pruritus—Pazopanib—kidney cancer	0.000284	0.00118	CcSEcCtD
Vorinostat—Anaemia—Dactinomycin—kidney cancer	0.000284	0.00118	CcSEcCtD
Vorinostat—Cough—Sunitinib—kidney cancer	0.000283	0.00118	CcSEcCtD
Vorinostat—Weight decreased—Paclitaxel—kidney cancer	0.000283	0.00118	CcSEcCtD
Vorinostat—Hyperglycaemia—Paclitaxel—kidney cancer	0.000282	0.00118	CcSEcCtD
Vorinostat—Dizziness—Temsirolimus—kidney cancer	0.000282	0.00117	CcSEcCtD
Vorinostat—Dry mouth—Sorafenib—kidney cancer	0.000281	0.00117	CcSEcCtD
Vorinostat—Alopecia—Vincristine—kidney cancer	0.000279	0.00116	CcSEcCtD
Vorinostat—Blood creatinine increased—Capecitabine—kidney cancer	0.000279	0.00116	CcSEcCtD
Vorinostat—Decreased appetite—Vinblastine—kidney cancer	0.000277	0.00115	CcSEcCtD
Vorinostat—Chest pain—Sunitinib—kidney cancer	0.000276	0.00115	CcSEcCtD
Vorinostat—Dehydration—Capecitabine—kidney cancer	0.000276	0.00115	CcSEcCtD
Vorinostat—Decreased appetite—Everolimus—kidney cancer	0.000276	0.00115	CcSEcCtD
Vorinostat—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000275	0.00115	CcSEcCtD
Vorinostat—Leukopenia—Dactinomycin—kidney cancer	0.000275	0.00115	CcSEcCtD
Vorinostat—Diarrhoea—Pazopanib—kidney cancer	0.000275	0.00114	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Everolimus—kidney cancer	0.000274	0.00114	CcSEcCtD
Vorinostat—Myocardial infarction—Paclitaxel—kidney cancer	0.000274	0.00114	CcSEcCtD
Vorinostat—Infection—Sorafenib—kidney cancer	0.000274	0.00114	CcSEcCtD
Vorinostat—Fatigue—Everolimus—kidney cancer	0.000274	0.00114	CcSEcCtD
Vorinostat—Constipation—Vinblastine—kidney cancer	0.000272	0.00113	CcSEcCtD
Vorinostat—Constipation—Everolimus—kidney cancer	0.000271	0.00113	CcSEcCtD
Vorinostat—Vomiting—Temsirolimus—kidney cancer	0.000271	0.00113	CcSEcCtD
Vorinostat—Shock—Sorafenib—kidney cancer	0.000271	0.00113	CcSEcCtD
Vorinostat—Hypokalaemia—Capecitabine—kidney cancer	0.000271	0.00113	CcSEcCtD
Vorinostat—Dry mouth—Sunitinib—kidney cancer	0.00027	0.00113	CcSEcCtD
Vorinostat—Thrombocytopenia—Sorafenib—kidney cancer	0.00027	0.00112	CcSEcCtD
Vorinostat—Chills—Gemcitabine—kidney cancer	0.000269	0.00112	CcSEcCtD
Vorinostat—Headache—Temsirolimus—kidney cancer	0.000267	0.00111	CcSEcCtD
Vorinostat—Decreased appetite—Erlotinib—kidney cancer	0.000266	0.00111	CcSEcCtD
Vorinostat—Dizziness—Pazopanib—kidney cancer	0.000266	0.00111	CcSEcCtD
Vorinostat—Alopecia—Gemcitabine—kidney cancer	0.000265	0.0011	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000264	0.0011	CcSEcCtD
Vorinostat—Pulmonary embolism—Doxorubicin—kidney cancer	0.000264	0.0011	CcSEcCtD
Vorinostat—Fatigue—Erlotinib—kidney cancer	0.000264	0.0011	CcSEcCtD
Vorinostat—Infection—Sunitinib—kidney cancer	0.000263	0.0011	CcSEcCtD
Vorinostat—Anorexia—Sorafenib—kidney cancer	0.000263	0.00109	CcSEcCtD
Vorinostat—Constipation—Erlotinib—kidney cancer	0.000262	0.00109	CcSEcCtD
Vorinostat—Shock—Sunitinib—kidney cancer	0.000261	0.00109	CcSEcCtD
Vorinostat—Thrombocytopenia—Sunitinib—kidney cancer	0.00026	0.00108	CcSEcCtD
Vorinostat—Vomiting—Pazopanib—kidney cancer	0.000256	0.00106	CcSEcCtD
Vorinostat—Anaemia—Vincristine—kidney cancer	0.000254	0.00106	CcSEcCtD
Vorinostat—Nausea—Temsirolimus—kidney cancer	0.000253	0.00105	CcSEcCtD
Vorinostat—Anorexia—Sunitinib—kidney cancer	0.000253	0.00105	CcSEcCtD
Vorinostat—Headache—Pazopanib—kidney cancer	0.000252	0.00105	CcSEcCtD
Vorinostat—Body temperature increased—Everolimus—kidney cancer	0.000251	0.00104	CcSEcCtD
Vorinostat—Infection—Dactinomycin—kidney cancer	0.000249	0.00104	CcSEcCtD
Vorinostat—Oedema peripheral—Paclitaxel—kidney cancer	0.000247	0.00103	CcSEcCtD
Vorinostat—Leukopenia—Vincristine—kidney cancer	0.000246	0.00102	CcSEcCtD
Vorinostat—Thrombocytopenia—Dactinomycin—kidney cancer	0.000246	0.00102	CcSEcCtD
Vorinostat—Pancytopenia—Capecitabine—kidney cancer	0.000244	0.00102	CcSEcCtD
Vorinostat—Body temperature increased—Erlotinib—kidney cancer	0.000242	0.00101	CcSEcCtD
Vorinostat—Anaemia—Gemcitabine—kidney cancer	0.000241	0.001	CcSEcCtD
Vorinostat—Neutropenia—Capecitabine—kidney cancer	0.00024	0.001	CcSEcCtD
Vorinostat—Decreased appetite—Sorafenib—kidney cancer	0.000239	0.000997	CcSEcCtD
Vorinostat—Anorexia—Dactinomycin—kidney cancer	0.000239	0.000996	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000239	0.000994	CcSEcCtD
Vorinostat—Nausea—Pazopanib—kidney cancer	0.000239	0.000994	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000238	0.00099	CcSEcCtD
Vorinostat—Fatigue—Sorafenib—kidney cancer	0.000237	0.000989	CcSEcCtD
Vorinostat—Constipation—Sorafenib—kidney cancer	0.000236	0.000981	CcSEcCtD
Vorinostat—Leukopenia—Gemcitabine—kidney cancer	0.000233	0.000971	CcSEcCtD
Vorinostat—Weight decreased—Capecitabine—kidney cancer	0.000232	0.000968	CcSEcCtD
Vorinostat—Hyperglycaemia—Capecitabine—kidney cancer	0.000232	0.000965	CcSEcCtD
Vorinostat—Decreased appetite—Sunitinib—kidney cancer	0.00023	0.000959	CcSEcCtD
Vorinostat—Sepsis—Doxorubicin—kidney cancer	0.000229	0.000954	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000229	0.000953	CcSEcCtD
Vorinostat—Asthenia—Vinblastine—kidney cancer	0.000229	0.000952	CcSEcCtD
Vorinostat—Fatigue—Sunitinib—kidney cancer	0.000229	0.000951	CcSEcCtD
Vorinostat—Asthenia—Everolimus—kidney cancer	0.000228	0.000948	CcSEcCtD
Vorinostat—Cough—Gemcitabine—kidney cancer	0.000227	0.000947	CcSEcCtD
Vorinostat—Constipation—Sunitinib—kidney cancer	0.000227	0.000944	CcSEcCtD
Vorinostat—Acute coronary syndrome—Capecitabine—kidney cancer	0.000226	0.00094	CcSEcCtD
Vorinostat—Chills—Paclitaxel—kidney cancer	0.000225	0.000936	CcSEcCtD
Vorinostat—Myocardial infarction—Capecitabine—kidney cancer	0.000225	0.000935	CcSEcCtD
Vorinostat—Pruritus—Everolimus—kidney cancer	0.000224	0.000935	CcSEcCtD
Vorinostat—Infection—Vincristine—kidney cancer	0.000223	0.000927	CcSEcCtD
Vorinostat—Chest pain—Gemcitabine—kidney cancer	0.000222	0.000924	CcSEcCtD
Vorinostat—Alopecia—Paclitaxel—kidney cancer	0.000221	0.000922	CcSEcCtD
Vorinostat—Asthenia—Erlotinib—kidney cancer	0.00022	0.000915	CcSEcCtD
Vorinostat—Thrombocytopenia—Vincristine—kidney cancer	0.000219	0.000914	CcSEcCtD
Vorinostat—Decreased appetite—Dactinomycin—kidney cancer	0.000218	0.000908	CcSEcCtD
Vorinostat—Diarrhoea—Vinblastine—kidney cancer	0.000218	0.000907	CcSEcCtD
Vorinostat—Body temperature increased—Sorafenib—kidney cancer	0.000218	0.000907	CcSEcCtD
Vorinostat—Diarrhoea—Everolimus—kidney cancer	0.000217	0.000904	CcSEcCtD
Vorinostat—Pruritus—Erlotinib—kidney cancer	0.000217	0.000902	CcSEcCtD
Vorinostat—Fatigue—Dactinomycin—kidney cancer	0.000216	0.000901	CcSEcCtD
Vorinostat—Anorexia—Vincristine—kidney cancer	0.000214	0.00089	CcSEcCtD
Vorinostat—Dysgeusia—Paclitaxel—kidney cancer	0.000214	0.000889	CcSEcCtD
Vorinostat—Infection—Gemcitabine—kidney cancer	0.000211	0.00088	CcSEcCtD
Vorinostat—Dizziness—Vinblastine—kidney cancer	0.000211	0.000877	CcSEcCtD
Vorinostat—Dizziness—Everolimus—kidney cancer	0.00021	0.000874	CcSEcCtD
Vorinostat—Muscle spasms—Paclitaxel—kidney cancer	0.00021	0.000873	CcSEcCtD
Vorinostat—Body temperature increased—Sunitinib—kidney cancer	0.00021	0.000872	CcSEcCtD
Vorinostat—Diarrhoea—Erlotinib—kidney cancer	0.000209	0.000872	CcSEcCtD
Vorinostat—Thrombocytopenia—Gemcitabine—kidney cancer	0.000208	0.000867	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000203	0.000846	CcSEcCtD
Vorinostat—Anorexia—Gemcitabine—kidney cancer	0.000203	0.000844	CcSEcCtD
Vorinostat—Oedema peripheral—Capecitabine—kidney cancer	0.000203	0.000844	CcSEcCtD
Vorinostat—Vomiting—Vinblastine—kidney cancer	0.000203	0.000843	CcSEcCtD
Vorinostat—Dizziness—Erlotinib—kidney cancer	0.000202	0.000843	CcSEcCtD
Vorinostat—Vomiting—Everolimus—kidney cancer	0.000202	0.00084	CcSEcCtD
Vorinostat—Anaemia—Paclitaxel—kidney cancer	0.000202	0.00084	CcSEcCtD
Vorinostat—Headache—Vinblastine—kidney cancer	0.0002	0.000831	CcSEcCtD
Vorinostat—Angioedema—Paclitaxel—kidney cancer	0.000199	0.00083	CcSEcCtD
Vorinostat—Headache—Everolimus—kidney cancer	0.000199	0.000828	CcSEcCtD
Vorinostat—Body temperature increased—Dactinomycin—kidney cancer	0.000198	0.000826	CcSEcCtD
Vorinostat—Asthenia—Sorafenib—kidney cancer	0.000198	0.000823	CcSEcCtD
Vorinostat—Syncope—Paclitaxel—kidney cancer	0.000196	0.000815	CcSEcCtD
Vorinostat—Lethargy—Doxorubicin—kidney cancer	0.000196	0.000814	CcSEcCtD
Vorinostat—Leukopenia—Paclitaxel—kidney cancer	0.000195	0.000813	CcSEcCtD
Vorinostat—Decreased appetite—Vincristine—kidney cancer	0.000195	0.000811	CcSEcCtD
Vorinostat—Pruritus—Sorafenib—kidney cancer	0.000195	0.000811	CcSEcCtD
Vorinostat—Vomiting—Erlotinib—kidney cancer	0.000195	0.00081	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Vincristine—kidney cancer	0.000194	0.000806	CcSEcCtD
Vorinostat—Fatigue—Vincristine—kidney cancer	0.000193	0.000805	CcSEcCtD
Vorinostat—Headache—Erlotinib—kidney cancer	0.000192	0.000799	CcSEcCtD
Vorinostat—Loss of consciousness—Paclitaxel—kidney cancer	0.000192	0.000798	CcSEcCtD
Vorinostat—Constipation—Vincristine—kidney cancer	0.000192	0.000798	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000192	0.000798	CcSEcCtD
Vorinostat—Cough—Paclitaxel—kidney cancer	0.00019	0.000793	CcSEcCtD
Vorinostat—Asthenia—Sunitinib—kidney cancer	0.00019	0.000792	CcSEcCtD
Vorinostat—Nausea—Vinblastine—kidney cancer	0.000189	0.000788	CcSEcCtD
Vorinostat—Nausea—Everolimus—kidney cancer	0.000188	0.000785	CcSEcCtD
Vorinostat—Diarrhoea—Sorafenib—kidney cancer	0.000188	0.000785	CcSEcCtD
Vorinostat—Pruritus—Sunitinib—kidney cancer	0.000188	0.000781	CcSEcCtD
Vorinostat—Chest pain—Paclitaxel—kidney cancer	0.000186	0.000773	CcSEcCtD
Vorinostat—Decreased appetite—Gemcitabine—kidney cancer	0.000185	0.00077	CcSEcCtD
Vorinostat—Chills—Capecitabine—kidney cancer	0.000185	0.000768	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000184	0.000764	CcSEcCtD
Vorinostat—Fatigue—Gemcitabine—kidney cancer	0.000183	0.000763	CcSEcCtD
Vorinostat—Dizziness—Sorafenib—kidney cancer	0.000182	0.000758	CcSEcCtD
Vorinostat—Constipation—Gemcitabine—kidney cancer	0.000182	0.000757	CcSEcCtD
Vorinostat—Nausea—Erlotinib—kidney cancer	0.000182	0.000757	CcSEcCtD
Vorinostat—Alopecia—Capecitabine—kidney cancer	0.000182	0.000757	CcSEcCtD
Vorinostat—Dry mouth—Paclitaxel—kidney cancer	0.000182	0.000756	CcSEcCtD
Vorinostat—Diarrhoea—Sunitinib—kidney cancer	0.000181	0.000755	CcSEcCtD
Vorinostat—Asthenia—Dactinomycin—kidney cancer	0.00018	0.00075	CcSEcCtD
Vorinostat—Blood creatinine increased—Doxorubicin—kidney cancer	0.00018	0.000747	CcSEcCtD
Vorinostat—Dehydration—Doxorubicin—kidney cancer	0.000178	0.000742	CcSEcCtD
Vorinostat—Body temperature increased—Vincristine—kidney cancer	0.000177	0.000738	CcSEcCtD
Vorinostat—Infection—Paclitaxel—kidney cancer	0.000177	0.000736	CcSEcCtD
Vorinostat—Dysgeusia—Capecitabine—kidney cancer	0.000175	0.00073	CcSEcCtD
Vorinostat—Dizziness—Sunitinib—kidney cancer	0.000175	0.00073	CcSEcCtD
Vorinostat—Shock—Paclitaxel—kidney cancer	0.000175	0.000729	CcSEcCtD
Vorinostat—Vomiting—Sorafenib—kidney cancer	0.000175	0.000729	CcSEcCtD
Vorinostat—Hypokalaemia—Doxorubicin—kidney cancer	0.000174	0.000726	CcSEcCtD
Vorinostat—Thrombocytopenia—Paclitaxel—kidney cancer	0.000174	0.000726	CcSEcCtD
Vorinostat—Headache—Sorafenib—kidney cancer	0.000173	0.000718	CcSEcCtD
Vorinostat—Muscle spasms—Capecitabine—kidney cancer	0.000172	0.000717	CcSEcCtD
Vorinostat—Diarrhoea—Dactinomycin—kidney cancer	0.000172	0.000715	CcSEcCtD
Vorinostat—Anorexia—Paclitaxel—kidney cancer	0.00017	0.000707	CcSEcCtD
Vorinostat—Vomiting—Sunitinib—kidney cancer	0.000169	0.000702	CcSEcCtD
Vorinostat—Body temperature increased—Gemcitabine—kidney cancer	0.000168	0.0007	CcSEcCtD
Vorinostat—Headache—Sunitinib—kidney cancer	0.000166	0.000691	CcSEcCtD
Vorinostat—Anaemia—Capecitabine—kidney cancer	0.000165	0.000689	CcSEcCtD
Vorinostat—Nausea—Sorafenib—kidney cancer	0.000164	0.000681	CcSEcCtD
Vorinostat—Asthenia—Vincristine—kidney cancer	0.000161	0.00067	CcSEcCtD
Vorinostat—Syncope—Capecitabine—kidney cancer	0.000161	0.000668	CcSEcCtD
Vorinostat—Leukopenia—Capecitabine—kidney cancer	0.00016	0.000667	CcSEcCtD
Vorinostat—Vomiting—Dactinomycin—kidney cancer	0.00016	0.000664	CcSEcCtD
Vorinostat—Nausea—Sunitinib—kidney cancer	0.000157	0.000655	CcSEcCtD
Vorinostat—Loss of consciousness—Capecitabine—kidney cancer	0.000157	0.000655	CcSEcCtD
Vorinostat—Pancytopenia—Doxorubicin—kidney cancer	0.000157	0.000655	CcSEcCtD
Vorinostat—Cough—Capecitabine—kidney cancer	0.000156	0.00065	CcSEcCtD
Vorinostat—Neutropenia—Doxorubicin—kidney cancer	0.000155	0.000645	CcSEcCtD
Vorinostat—Decreased appetite—Paclitaxel—kidney cancer	0.000155	0.000644	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000154	0.000641	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000154	0.00064	CcSEcCtD
Vorinostat—Fatigue—Paclitaxel—kidney cancer	0.000154	0.000639	CcSEcCtD
Vorinostat—Diarrhoea—Vincristine—kidney cancer	0.000153	0.000639	CcSEcCtD
Vorinostat—Asthenia—Gemcitabine—kidney cancer	0.000153	0.000635	CcSEcCtD
Vorinostat—Chest pain—Capecitabine—kidney cancer	0.000152	0.000635	CcSEcCtD
Vorinostat—Constipation—Paclitaxel—kidney cancer	0.000152	0.000634	CcSEcCtD
Vorinostat—Pruritus—Gemcitabine—kidney cancer	0.00015	0.000626	CcSEcCtD
Vorinostat—Weight decreased—Doxorubicin—kidney cancer	0.00015	0.000624	CcSEcCtD
Vorinostat—Hyperglycaemia—Doxorubicin—kidney cancer	0.000149	0.000622	CcSEcCtD
Vorinostat—Dry mouth—Capecitabine—kidney cancer	0.000149	0.000621	CcSEcCtD
Vorinostat—Nausea—Dactinomycin—kidney cancer	0.000149	0.000621	CcSEcCtD
Vorinostat—Dizziness—Vincristine—kidney cancer	0.000148	0.000617	CcSEcCtD
Vorinostat—Diarrhoea—Gemcitabine—kidney cancer	0.000146	0.000606	CcSEcCtD
Vorinostat—Infection—Capecitabine—kidney cancer	0.000145	0.000604	CcSEcCtD
Vorinostat—Shock—Capecitabine—kidney cancer	0.000144	0.000599	CcSEcCtD
Vorinostat—Thrombocytopenia—Capecitabine—kidney cancer	0.000143	0.000596	CcSEcCtD
Vorinostat—Vomiting—Vincristine—kidney cancer	0.000143	0.000593	CcSEcCtD
Vorinostat—Body temperature increased—Paclitaxel—kidney cancer	0.000141	0.000586	CcSEcCtD
Vorinostat—Headache—Vincristine—kidney cancer	0.00014	0.000585	CcSEcCtD
Vorinostat—Anorexia—Capecitabine—kidney cancer	0.000139	0.00058	CcSEcCtD
Vorinostat—Vomiting—Gemcitabine—kidney cancer	0.000135	0.000563	CcSEcCtD
Vorinostat—Headache—Gemcitabine—kidney cancer	0.000133	0.000555	CcSEcCtD
Vorinostat—Nausea—Vincristine—kidney cancer	0.000133	0.000554	CcSEcCtD
Vorinostat—Oedema peripheral—Doxorubicin—kidney cancer	0.000131	0.000544	CcSEcCtD
Vorinostat—Asthenia—Paclitaxel—kidney cancer	0.000128	0.000532	CcSEcCtD
Vorinostat—Decreased appetite—Capecitabine—kidney cancer	0.000127	0.000529	CcSEcCtD
Vorinostat—Nausea—Gemcitabine—kidney cancer	0.000126	0.000526	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000126	0.000525	CcSEcCtD
Vorinostat—Fatigue—Capecitabine—kidney cancer	0.000126	0.000524	CcSEcCtD
Vorinostat—Pruritus—Paclitaxel—kidney cancer	0.000126	0.000524	CcSEcCtD
Vorinostat—Constipation—Capecitabine—kidney cancer	0.000125	0.00052	CcSEcCtD
Vorinostat—Diarrhoea—Paclitaxel—kidney cancer	0.000122	0.000507	CcSEcCtD
Vorinostat—Chills—Doxorubicin—kidney cancer	0.000119	0.000495	CcSEcCtD
Vorinostat—Dizziness—Paclitaxel—kidney cancer	0.000118	0.00049	CcSEcCtD
Vorinostat—Alopecia—Doxorubicin—kidney cancer	0.000117	0.000488	CcSEcCtD
Vorinostat—Body temperature increased—Capecitabine—kidney cancer	0.000116	0.000481	CcSEcCtD
Vorinostat—Vomiting—Paclitaxel—kidney cancer	0.000113	0.000471	CcSEcCtD
Vorinostat—Dysgeusia—Doxorubicin—kidney cancer	0.000113	0.000471	CcSEcCtD
Vorinostat—Headache—Paclitaxel—kidney cancer	0.000112	0.000464	CcSEcCtD
Vorinostat—Muscle spasms—Doxorubicin—kidney cancer	0.000111	0.000462	CcSEcCtD
Vorinostat—Anaemia—Doxorubicin—kidney cancer	0.000107	0.000444	CcSEcCtD
Vorinostat—Nausea—Paclitaxel—kidney cancer	0.000106	0.00044	CcSEcCtD
Vorinostat—Asthenia—Capecitabine—kidney cancer	0.000105	0.000436	CcSEcCtD
Vorinostat—Syncope—Doxorubicin—kidney cancer	0.000103	0.000431	CcSEcCtD
Vorinostat—Pruritus—Capecitabine—kidney cancer	0.000103	0.00043	CcSEcCtD
Vorinostat—Leukopenia—Doxorubicin—kidney cancer	0.000103	0.00043	CcSEcCtD
Vorinostat—Loss of consciousness—Doxorubicin—kidney cancer	0.000101	0.000422	CcSEcCtD
Vorinostat—Cough—Doxorubicin—kidney cancer	0.000101	0.000419	CcSEcCtD
Vorinostat—Diarrhoea—Capecitabine—kidney cancer	0.0001	0.000416	CcSEcCtD
Vorinostat—Chest pain—Doxorubicin—kidney cancer	9.83e-05	0.000409	CcSEcCtD
Vorinostat—Dizziness—Capecitabine—kidney cancer	9.66e-05	0.000402	CcSEcCtD
Vorinostat—Dry mouth—Doxorubicin—kidney cancer	9.61e-05	0.0004	CcSEcCtD
Vorinostat—Infection—Doxorubicin—kidney cancer	9.36e-05	0.00039	CcSEcCtD
Vorinostat—Vomiting—Capecitabine—kidney cancer	9.29e-05	0.000387	CcSEcCtD
Vorinostat—Shock—Doxorubicin—kidney cancer	9.27e-05	0.000386	CcSEcCtD
Vorinostat—Thrombocytopenia—Doxorubicin—kidney cancer	9.22e-05	0.000384	CcSEcCtD
Vorinostat—Headache—Capecitabine—kidney cancer	9.15e-05	0.000381	CcSEcCtD
Vorinostat—Anorexia—Doxorubicin—kidney cancer	8.98e-05	0.000374	CcSEcCtD
Vorinostat—Nausea—Capecitabine—kidney cancer	8.68e-05	0.000361	CcSEcCtD
Vorinostat—Decreased appetite—Doxorubicin—kidney cancer	8.19e-05	0.000341	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.13e-05	0.000339	CcSEcCtD
Vorinostat—Fatigue—Doxorubicin—kidney cancer	8.12e-05	0.000338	CcSEcCtD
Vorinostat—Constipation—Doxorubicin—kidney cancer	8.05e-05	0.000335	CcSEcCtD
Vorinostat—Body temperature increased—Doxorubicin—kidney cancer	7.45e-05	0.00031	CcSEcCtD
Vorinostat—Asthenia—Doxorubicin—kidney cancer	6.76e-05	0.000281	CcSEcCtD
Vorinostat—Pruritus—Doxorubicin—kidney cancer	6.66e-05	0.000277	CcSEcCtD
Vorinostat—Diarrhoea—Doxorubicin—kidney cancer	6.44e-05	0.000268	CcSEcCtD
Vorinostat—Dizziness—Doxorubicin—kidney cancer	6.23e-05	0.000259	CcSEcCtD
Vorinostat—Vomiting—Doxorubicin—kidney cancer	5.99e-05	0.000249	CcSEcCtD
Vorinostat—Headache—Doxorubicin—kidney cancer	5.9e-05	0.000246	CcSEcCtD
Vorinostat—Nausea—Doxorubicin—kidney cancer	5.59e-05	0.000233	CcSEcCtD
Vorinostat—HDAC4—Signaling Pathways—ERBB2—kidney cancer	1.75e-05	7.68e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KIT—kidney cancer	1.75e-05	7.67e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—APC—kidney cancer	1.75e-05	7.67e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—TP53—kidney cancer	1.75e-05	7.66e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KDR—kidney cancer	1.75e-05	7.65e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PTGS2—kidney cancer	1.74e-05	7.64e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—MAPK1—kidney cancer	1.74e-05	7.6e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MTOR—kidney cancer	1.73e-05	7.58e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN2B—kidney cancer	1.71e-05	7.51e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CCND1—kidney cancer	1.71e-05	7.5e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—JUN—kidney cancer	1.71e-05	7.49e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—CTNNB1—kidney cancer	1.7e-05	7.44e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CTNNB1—kidney cancer	1.7e-05	7.43e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—MAPK3—kidney cancer	1.69e-05	7.38e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—MAPK3—kidney cancer	1.68e-05	7.38e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—POMC—kidney cancer	1.67e-05	7.3e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—PIK3CA—kidney cancer	1.67e-05	7.3e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PTEN—kidney cancer	1.66e-05	7.25e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PTEN—kidney cancer	1.65e-05	7.24e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CDKN1B—kidney cancer	1.65e-05	7.24e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—TP53—kidney cancer	1.65e-05	7.23e-05	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—MAPK3—kidney cancer	1.65e-05	7.21e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—BRAF—kidney cancer	1.65e-05	7.21e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PSMD7—kidney cancer	1.64e-05	7.19e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ANXA1—kidney cancer	1.64e-05	7.19e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TSC1—kidney cancer	1.64e-05	7.19e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—MYC—kidney cancer	1.64e-05	7.18e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—KRAS—kidney cancer	1.64e-05	7.18e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—MYC—kidney cancer	1.64e-05	7.17e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—RAF1—kidney cancer	1.64e-05	7.16e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—RELA—kidney cancer	1.63e-05	7.13e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CDKN1B—kidney cancer	1.62e-05	7.11e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—ERBB2—kidney cancer	1.62e-05	7.09e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KIT—kidney cancer	1.61e-05	7.05e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—APC—kidney cancer	1.61e-05	7.05e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—MAPK1—kidney cancer	1.6e-05	7.03e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—MAPK1—kidney cancer	1.6e-05	7.02e-05	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—MYC—kidney cancer	1.6e-05	7.02e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MTOR—kidney cancer	1.6e-05	6.99e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FLT1—kidney cancer	1.59e-05	6.97e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PTGS2—kidney cancer	1.59e-05	6.96e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IL2—kidney cancer	1.59e-05	6.96e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—MAPK3—kidney cancer	1.58e-05	6.9e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CTNNB1—kidney cancer	1.56e-05	6.84e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CCND1—kidney cancer	1.55e-05	6.79e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—JUN—kidney cancer	1.55e-05	6.77e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CTNNB1—kidney cancer	1.53e-05	6.72e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—MYC—kidney cancer	1.53e-05	6.71e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—POMC—kidney cancer	1.53e-05	6.71e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—RAF1—kidney cancer	1.53e-05	6.7e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—RELA—kidney cancer	1.52e-05	6.67e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PTEN—kidney cancer	1.52e-05	6.66e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—KRAS—kidney cancer	1.52e-05	6.64e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—ERBB2—kidney cancer	1.51e-05	6.63e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—KRAS—kidney cancer	1.51e-05	6.63e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—BRAF—kidney cancer	1.51e-05	6.63e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—PIK3CA—kidney cancer	1.51e-05	6.6e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CDKN1B—kidney cancer	1.5e-05	6.56e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—MAPK1—kidney cancer	1.5e-05	6.56e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PTEN—kidney cancer	1.5e-05	6.55e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MTOR—kidney cancer	1.49e-05	6.54e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—VEGFA—kidney cancer	1.49e-05	6.54e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—VEGFA—kidney cancer	1.49e-05	6.53e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HIF1A—kidney cancer	1.49e-05	6.52e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TSC2—kidney cancer	1.49e-05	6.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PAK1—kidney cancer	1.47e-05	6.46e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—JUNB—kidney cancer	1.47e-05	6.46e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—RAF1—kidney cancer	1.47e-05	6.44e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IL2—kidney cancer	1.47e-05	6.42e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTGS2—kidney cancer	1.46e-05	6.4e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—ERBB2—kidney cancer	1.45e-05	6.37e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MTOR—kidney cancer	1.44e-05	6.29e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CD4—kidney cancer	1.43e-05	6.28e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CCND1—kidney cancer	1.43e-05	6.26e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—JUN—kidney cancer	1.43e-05	6.25e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KDR—kidney cancer	1.42e-05	6.24e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTGS2—kidney cancer	1.42e-05	6.23e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CTNNB1—kidney cancer	1.42e-05	6.2e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—KRAS—kidney cancer	1.42e-05	6.2e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MAPK3—kidney cancer	1.41e-05	6.2e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MAPK3—kidney cancer	1.41e-05	6.19e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—MAPK3—kidney cancer	1.41e-05	6.18e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CDKN1B—kidney cancer	1.4e-05	6.14e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—MAPK3—kidney cancer	1.4e-05	6.13e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—PIK3CA—kidney cancer	1.39e-05	6.1e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—PIK3CA—kidney cancer	1.39e-05	6.09e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PTEN—kidney cancer	1.39e-05	6.07e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PTEN—kidney cancer	1.38e-05	6.04e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MYC—kidney cancer	1.38e-05	6.03e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—RAF1—kidney cancer	1.37e-05	6.02e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MYC—kidney cancer	1.37e-05	6.02e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IL2—kidney cancer	1.37e-05	6.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HIF1A—kidney cancer	1.37e-05	6e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—RELA—kidney cancer	1.37e-05	5.99e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—TSC2—kidney cancer	1.37e-05	5.99e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—MYC—kidney cancer	1.36e-05	5.96e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—ERBB2—kidney cancer	1.36e-05	5.96e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—VEGFA—kidney cancer	1.35e-05	5.92e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CDKN1B—kidney cancer	1.35e-05	5.9e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TP53—kidney cancer	1.35e-05	5.9e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MAPK1—kidney cancer	1.35e-05	5.9e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MAPK1—kidney cancer	1.34e-05	5.89e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—MAPK1—kidney cancer	1.34e-05	5.88e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MTOR—kidney cancer	1.34e-05	5.88e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CCND1—kidney cancer	1.34e-05	5.86e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—JUN—kidney cancer	1.33e-05	5.85e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CTNNB1—kidney cancer	1.32e-05	5.8e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—APC—kidney cancer	1.31e-05	5.75e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KIT—kidney cancer	1.31e-05	5.75e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—PIK3CA—kidney cancer	1.3e-05	5.7e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MAPK3—kidney cancer	1.3e-05	5.69e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PTEN—kidney cancer	1.29e-05	5.65e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MAPK3—kidney cancer	1.28e-05	5.6e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTEN—kidney cancer	1.27e-05	5.58e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CTNNB1—kidney cancer	1.27e-05	5.57e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—KRAS—kidney cancer	1.27e-05	5.57e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—KRAS—kidney cancer	1.27e-05	5.56e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—KRAS—kidney cancer	1.27e-05	5.55e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MYC—kidney cancer	1.26e-05	5.54e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—RAF1—kidney cancer	1.26e-05	5.53e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CDKN1B—kidney cancer	1.26e-05	5.52e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—RELA—kidney cancer	1.26e-05	5.51e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—ERBB2—kidney cancer	1.25e-05	5.47e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—POMC—kidney cancer	1.25e-05	5.47e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—kidney cancer	1.25e-05	5.46e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MYC—kidney cancer	1.24e-05	5.44e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTEN—kidney cancer	1.24e-05	5.43e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MAPK1—kidney cancer	1.24e-05	5.42e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MTOR—kidney cancer	1.23e-05	5.4e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—BRAF—kidney cancer	1.23e-05	5.4e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL2—kidney cancer	1.23e-05	5.4e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MAPK1—kidney cancer	1.22e-05	5.32e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KIT—kidney cancer	1.21e-05	5.29e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APC—kidney cancer	1.21e-05	5.29e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF2—kidney cancer	1.21e-05	5.28e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCND1—kidney cancer	1.2e-05	5.26e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN2B—kidney cancer	1.2e-05	5.26e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—JUN—kidney cancer	1.2e-05	5.25e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CTNNB1—kidney cancer	1.19e-05	5.21e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MAPK3—kidney cancer	1.18e-05	5.16e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—KRAS—kidney cancer	1.17e-05	5.12e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PIK3CA—kidney cancer	1.17e-05	5.12e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PIK3CA—kidney cancer	1.17e-05	5.11e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—kidney cancer	1.17e-05	5.11e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF1R—kidney cancer	1.17e-05	5.1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—PIK3CA—kidney cancer	1.16e-05	5.1e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PTEN—kidney cancer	1.16e-05	5.08e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CDKN1B—kidney cancer	1.16e-05	5.07e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KRAS—kidney cancer	1.15e-05	5.03e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MYC—kidney cancer	1.15e-05	5.02e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MAPK3—kidney cancer	1.14e-05	5e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—BRAF—kidney cancer	1.13e-05	4.97e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL2—kidney cancer	1.13e-05	4.96e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—kidney cancer	1.13e-05	4.94e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—kidney cancer	1.13e-05	4.94e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MAPK1—kidney cancer	1.12e-05	4.91e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MYC—kidney cancer	1.11e-05	4.86e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCND1—kidney cancer	1.1e-05	4.84e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MAPK3—kidney cancer	1.1e-05	4.83e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—JUN—kidney cancer	1.1e-05	4.82e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CTNNB1—kidney cancer	1.09e-05	4.79e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PIK3CA—kidney cancer	1.07e-05	4.7e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MYC—kidney cancer	1.07e-05	4.7e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PTEN—kidney cancer	1.07e-05	4.67e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MAPK3—kidney cancer	1.06e-05	4.64e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KRAS—kidney cancer	1.06e-05	4.64e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PIK3CA—kidney cancer	1.06e-05	4.62e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MAPK1—kidney cancer	1.05e-05	4.6e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—kidney cancer	1.05e-05	4.59e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MYC—kidney cancer	1.03e-05	4.51e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—RAF1—kidney cancer	1.03e-05	4.51e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—RELA—kidney cancer	1.03e-05	4.49e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—kidney cancer	1.02e-05	4.47e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—ERBB2—kidney cancer	1.02e-05	4.46e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MAPK1—kidney cancer	1.01e-05	4.42e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MTOR—kidney cancer	1.01e-05	4.4e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KRAS—kidney cancer	9.91e-06	4.34e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MAPK3—kidney cancer	9.91e-06	4.34e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PIK3CA—kidney cancer	9.78e-06	4.28e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PIK3CA—kidney cancer	9.74e-06	4.26e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MYC—kidney cancer	9.64e-06	4.22e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—kidney cancer	9.63e-06	4.22e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HIF1A—kidney cancer	9.6e-06	4.2e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TSC2—kidney cancer	9.57e-06	4.19e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KRAS—kidney cancer	9.53e-06	4.17e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—RAF1—kidney cancer	9.48e-06	4.15e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CDKN1B—kidney cancer	9.43e-06	4.13e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MAPK1—kidney cancer	9.43e-06	4.13e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—kidney cancer	9.42e-06	4.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ERBB2—kidney cancer	9.37e-06	4.11e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MTOR—kidney cancer	9.25e-06	4.05e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CD4—kidney cancer	9.23e-06	4.04e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL2—kidney cancer	9.23e-06	4.04e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KDR—kidney cancer	9.18e-06	4.02e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTGS2—kidney cancer	9.17e-06	4.01e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PIK3CA—kidney cancer	9.11e-06	3.99e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MAPK3—kidney cancer	9.11e-06	3.99e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCND1—kidney cancer	9e-06	3.94e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PIK3CA—kidney cancer	8.99e-06	3.94e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—JUN—kidney cancer	8.98e-06	3.93e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CTNNB1—kidney cancer	8.91e-06	3.9e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KRAS—kidney cancer	8.9e-06	3.9e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MYC—kidney cancer	8.86e-06	3.88e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—kidney cancer	8.81e-06	3.86e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PIK3CA—kidney cancer	8.75e-06	3.83e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PTEN—kidney cancer	8.69e-06	3.8e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN1B—kidney cancer	8.68e-06	3.8e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MAPK1—kidney cancer	8.66e-06	3.79e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APC—kidney cancer	8.45e-06	3.7e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KIT—kidney cancer	8.45e-06	3.7e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CTNNB1—kidney cancer	8.2e-06	3.59e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KRAS—kidney cancer	8.18e-06	3.58e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PIK3CA—kidney cancer	8.18e-06	3.58e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—POMC—kidney cancer	8.05e-06	3.52e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTEN—kidney cancer	7.99e-06	3.5e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—BRAF—kidney cancer	7.95e-06	3.48e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—kidney cancer	7.91e-06	3.47e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—kidney cancer	7.85e-06	3.44e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CA—kidney cancer	7.52e-06	3.29e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MAPK3—kidney cancer	7.42e-06	3.25e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MAPK3—kidney cancer	7.36e-06	3.22e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—kidney cancer	7.27e-06	3.18e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MYC—kidney cancer	7.22e-06	3.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MYC—kidney cancer	7.15e-06	3.13e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MAPK1—kidney cancer	7.06e-06	3.09e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MAPK3—kidney cancer	6.83e-06	2.99e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KRAS—kidney cancer	6.67e-06	2.92e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MYC—kidney cancer	6.64e-06	2.91e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—RAF1—kidney cancer	6.64e-06	2.91e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—RELA—kidney cancer	6.61e-06	2.89e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ERBB2—kidney cancer	6.56e-06	2.87e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MAPK1—kidney cancer	6.5e-06	2.85e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MTOR—kidney cancer	6.48e-06	2.84e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KRAS—kidney cancer	6.14e-06	2.69e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CA—kidney cancer	6.13e-06	2.68e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN1B—kidney cancer	6.08e-06	2.66e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL2—kidney cancer	5.95e-06	2.61e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—kidney cancer	5.93e-06	2.6e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCND1—kidney cancer	5.8e-06	2.54e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—JUN—kidney cancer	5.79e-06	2.53e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CTNNB1—kidney cancer	5.74e-06	2.52e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CA—kidney cancer	5.64e-06	2.47e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTEN—kidney cancer	5.6e-06	2.45e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—kidney cancer	5.06e-06	2.21e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MAPK3—kidney cancer	4.78e-06	2.09e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MYC—kidney cancer	4.65e-06	2.04e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MAPK1—kidney cancer	4.55e-06	1.99e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KRAS—kidney cancer	4.3e-06	1.88e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CA—kidney cancer	3.95e-06	1.73e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—kidney cancer	3.82e-06	1.67e-05	CbGpPWpGaD
